Clinical Trial Update: A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the RSVpreF vaccine in pregnant participants with HIV and their infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSVpreF

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus | Phase 3 | Status: COMPLETED